Literature DB >> 34642184

Reorganization of the 3D Genome Pinpoints Noncoding Drivers of Primary Prostate Tumors.

James R Hawley1,2, Stanley Zhou1,2, Christopher Arlidge1, Giacomo Grillo1, Ken J Kron1, Rupert Hugh-White3,4,5, Theodorus H van der Kwast6, Michael Fraser1,7, Paul C Boutros2,3,4,5,8,9, Robert G Bristow1,2,10,11,12,13, Mathieu Lupien14,2,15.   

Abstract

Prostate cancer is a heterogeneous disease whose progression is linked to genome instability. However, the impact of this instability on the noncoding genome and its three-dimensional organization to aid progression is unclear. Using primary benign and tumor tissue, we find a high concordance in higher-order three-dimensional genome organization. This concordance argues for constraints to the topology of prostate tumor genomes. Nonetheless, we identified changes in focal chromatin interactions, typical of loops bridging noncoding cis-regulatory elements, and showed how structural variants can induce these changes to guide cis-regulatory element hijacking. Such events resulted in opposing differential expression of genes found at antipodes of rearrangements. Collectively, these results argue that changes to focal chromatin interactions, as opposed to higher-order genome organization, allow for aberrant gene regulation and are repeatedly mediated by structural variants in primary prostate cancer. SIGNIFICANCE: This work showcases how the noncoding genome can be hijacked by focal insults to its three-dimensional organization that contribute to prostate cancer oncogenesis. ©2021 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34642184     DOI: 10.1158/0008-5472.CAN-21-2056

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  4 in total

1.  Genetic determinants of chromatin reveal prostate cancer risk mediated by context-dependent gene regulation.

Authors:  Sylvan C Baca; Cassandra Singler; Soumya Zacharia; Ji-Heui Seo; Tunc Morova; Faraz Hach; Yi Ding; Tommer Schwarz; Chia-Chi Flora Huang; Jacob Anderson; André P Fay; Cynthia Kalita; Stefan Groha; Mark M Pomerantz; Victoria Wang; Simon Linder; Christopher J Sweeney; Wilbert Zwart; Nathan A Lack; Bogdan Pasaniuc; David Y Takeda; Alexander Gusev; Matthew L Freedman
Journal:  Nat Genet       Date:  2022-09-07       Impact factor: 41.307

2.  Identification of Prostate Cancer Risk Genetics Biomarkers Based on Intergraded Bioinformatics Analysis.

Authors:  Xiangdong Liang; Yanchao Wang; Long Pei; Xiaoliang Tan; Chunhui Dong
Journal:  Front Surg       Date:  2022-03-17

Review 3.  Androgen Receptor-Mediated Transcription in Prostate Cancer.

Authors:  Doğancan Özturan; Tunç Morova; Nathan A Lack
Journal:  Cells       Date:  2022-03-05       Impact factor: 6.600

Review 4.  Unravelling the tumour genome: The evolutionary and clinical impacts of structural variants in tumourigenesis.

Authors:  Alhafidz Hamdan; Ailith Ewing
Journal:  J Pathol       Date:  2022-04-28       Impact factor: 9.883

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.